Skip to main content
OpenTrials

Clinical trial condition

Digestive System Neoplasms

Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.

14,516 public trials 3,333 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Neoplasms trial results

Recruiting

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

NCT07562152

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +17 more
Locations
  • City of Hope Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • Medical Oncology Hematology Consultants Newark, Delaware, United States
  • Hematology Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States
View all 51 locations
View Trial Details
Recruiting

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

NCT07277413

Conditions
Adenocarcinoma Of Esophagus, Adenocarcinoma of Esophagus, Adenoma, +55 more
Locations
  • Providence Medical Foundation Santa Rosa, California, United States
  • Johns Hopkins Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • BRCR Global-Coral Springs Coral Springs, Florida, United States
  • Sarah Cannon Research Institute at Florida Cancer Specialists Orlando, Florida, United States
View all 21 locations
View Trial Details
Recruiting

Evaluation of XYA02 in Patients With Advanced Solid Tumors

NCT07670312

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +38 more
Locations
  • Chris O'Brien Life House Sydney, New South Wales, Australia
  • Westmead Hospital Sydney, New South Wales, Australia
  • Monash Medical Centre Melbourne, Victoria, Australia
  • Peter MacCallum Cancer Centre Melbourne, Victoria, Australia
View Trial Details
Recruiting

Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial

NCT07271355

Conditions
Appendiceal Neoplasms, Cecal Diseases, Cecal Neoplasms, +17 more
Locations
  • CTCA at Western Regional Medical Center Goodyear, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • City of Hope Atlanta Cancer Center Newnan, Georgia, United States
View Trial Details
Recruiting

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

NCT07659795

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • START Los Angeles Los Angeles, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • START Midwest Grand Rapids, Michigan, United States
  • START New Jersey East Brunswick, New Jersey, United States
View all 18 locations
View Trial Details
Recruiting

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

NCT06750094

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +8 more
Locations
  • Ironwood Cancer and Research Center Chandler, Arizona, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Arizona Oncology Associates PC NAHOA Prescott, Arizona, United States
  • St. Bernard's Medical Center Jonesboro, Arkansas, United States
View all 251 locations
View Trial Details
Recruiting

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

NCT06989437

Conditions
Anorexia, Body Weight, Body Weight Changes, +19 more
Locations
  • The Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Central Arkansas Radiation Therapy Institute, dba CARTI Bryant, Arkansas, United States
View all 223 locations
View Trial Details
Recruiting

A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers

NCT06663319

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +8 more
Locations
  • University of Colorado Denver Anschultz Medical Campus Aurora, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Community Health Network Indianapolis, Indiana, United States
  • Start Midwest Grand Rapids, Michigan, United States
View Trial Details
Recruiting

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

NCT04924075

Conditions
Abnormalities, Multiple, Adenoma, Adenoma, Islet Cell, +31 more
Locations
  • Cedars-Sinai Medical Center ( Site 0110) Los Angeles, California, United States
  • Northwestern University - Robert H. Lurie Comprehensive Cancer Center ( Site 0130) Chicago, Illinois, United States
  • Northwestern Medicine Cancer Center - Warrenville ( Site 0134) Warrenville, Illinois, United States
  • University of Iowa ( Site 0104) Iowa City, Iowa, United States
View all 84 locations
View Trial Details

Related conditions